Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Biliary Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00654160
What this trial is testing

Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Anal CancerCarcinoma of the AppendixColorectal Cancer+9 more
Mayo Clinic 7
Testing effectiveness (Phase 2)UnknownNCT03943043
What this trial is testing

Gemcitabine + Oxaliplatin +Nab-paclitaxel in Subjects With Advanced Biliary Tract Cancer

Who this might be right for
Cholangiocarcinoma
Istituto Clinico Humanitas 85
Testing effectiveness (Phase 2)Active Not RecruitingNCT07635290
What this trial is testing

Anlotinib+Cadonilimab+PULSAR in Advanced Biliary Tract Cancer

Who this might be right for
Previously Treated, AdvancedBiliary Tract Cancers
West China Hospital 26
Testing effectiveness (Phase 2)WithdrawnNCT04571710
What this trial is testing

A Trial of SHR1258 in Patients With Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Jiangsu HengRui Medicine Co., Ltd.
Testing effectiveness (Phase 2)Study completedNCT01007552
What this trial is testing

Gemcitabine, Capecitabine and Bevacizumab to Treat Cancer of the Gall Bladder or Bile Ducts

Who this might be right for
Cholangiocarcinoma
Roswell Park Cancer Institute 50
Testing effectiveness (Phase 2)UnknownNCT04004234
What this trial is testing

A Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic BTC

Who this might be right for
Biliary Tract Cancer (BTC)
Chinese PLA General Hospital 20
Not applicableStudy completedNCT03222258
What this trial is testing

Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer Patients

Who this might be right for
Stage IV Breast CancerStage IV Pancreatic CancerStage IV Colon Cancer+9 more
Seoul National University Hospital 444
Testing effectiveness (Phase 2)UnknownNCT03185988
What this trial is testing

Anti-HER2 Therapy in Patients of HER2 Positive Metastatic Carcinoma of Digestive System

Who this might be right for
Targeted TherapyHER2Biliary Tract Cancer+2 more
Shen Lin 100
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT04426669
What this trial is testing

Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering

Who this might be right for
Gastrointestinal Epithelial CancerGastrointestinal NeoplasmsCancer of Gastrointestinal Tract+8 more
Intima Bioscience, Inc. 23
Testing effectiveness (Phase 2)WithdrawnNCT01859182
What this trial is testing

Selumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duct Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adenocarcinoma of the GallbladderAdenocarcinoma With Squamous Metaplasia of the GallbladderAdult Primary Cholangiocellular Carcinoma+12 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT01267344
What this trial is testing

Study of GEMOX With or Without Cetuximab in Locally Advanced and Metastatic BTC

Who this might be right for
CholangiocarcinomaAdenocarcinoma of Gallbladder
National Health Research Institutes, Taiwan 122
Early research (Phase 1)Ended earlyNCT02908451
What this trial is testing

AbGn-107 in Patients With Gastric, Colorectal, Pancreatic or Biliary Cancer

Who this might be right for
Gastric CancerColorectal CancerPancreatic Cancer+1 more
AbGenomics B.V Taiwan Branch 39
Large-scale testing (Phase 3)Looking for participantsNCT06467357
What this trial is testing

Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
AstraZeneca 620
Testing effectiveness (Phase 2)UnknownNCT05978609
What this trial is testing

Cadonilimab With Chemotherapy in Treating Advanced Biliary Cancer

Who this might be right for
Cholangiocarcinoma Non-resectable
West China Hospital 65
Testing effectiveness (Phase 2)Looking for participantsNCT07670273
What this trial is testing

Phase II Study of Trastuzumab Rezetecan Combined With Adebrelimab and Lenvatinib as First-Line Therapy for Advanced HER2-Positive/HER2-Low Biliary Tract Cancer

Who this might be right for
Biliary Tract Neoplasms Immunotherapy
Peking Union Medical College Hospital 70
Early research (Phase 1)Study completedNCT04338685
What this trial is testing

A Study Evaluating Safety, Pharmacokinetics, Pharmacodynamics, And Clinical Activity Of RO7119929 (TLR7 Agonist) In Participants With Unresectable Advanced Or Metastatic Hepatocellular Carcinoma, Biliary Tract Cancer, Or Solid Tumors With Hepatic Metastases

Who this might be right for
Carcinoma, HepatocellularBiliary Tract CancerSecondary Liver Cancer+1 more
Hoffmann-La Roche 55
Testing effectiveness (Phase 2)Study completedNCT03201458
What this trial is testing

Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer

Who this might be right for
Gallbladder CarcinomaMetastatic CholangiocarcinomaStage III Intrahepatic Cholangiocarcinoma AJCC v8+2 more
National Cancer Institute (NCI) 86
Testing effectiveness (Phase 2)Looking for participantsNCT07831993
What this trial is testing

Sintilimab Plus NALIRIFOX or Gemcitabine-Cisplatin as First-Line Treatment for Metastatic Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 54
Testing effectiveness (Phase 2)Study completedNCT00361231
What this trial is testing

Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Biliary Tract and Gallbladder Cancer

Who this might be right for
Biliary Tract CancerGallbladder Adenocarcinoma
Massachusetts General Hospital 35
Next Page